A Whole Hog of Problems
US congressional leaders demand answers as the risk of heparin shortages looms
Maryam Mahdi | | Quick Read
China’s recent African swine fever outbreak has left many within the US’ congressional body concerned. The reason? China remains its main source of heparin (an anticoagulant used in the treatment of angina and renal impairment) and with 440 million of the world’s supply of 770 million pigs, 80 percent of the world’s heparin supply is produced in China.
African swine fever is highly contagious and with no known cure, poses a threat to drugmakers who rely upon pig intestines to produce their heparin products. A bipartisan group of six congressional leaders expressed their concerns to Norman Sharpless, the FDA’s Acting Commissioner.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.